Valentis (VLTS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Valentis (VLTS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: gao seng who wrote (65)	12/28/2001 8:26:32 PM
From: Mike McFarland	of 81

psbiofund.com SAB is not given, but found this: Dr. Marc E. Lippman serves as chair of the Scientific Advisory Board for the Perseus-Soros Fund. Dr. Lippman is also a director of Raven Biotechnology. seattlegenetics.com quote.yahoo.com Hideous. Smart money buying in at $2 1/4? Seems like they always set the best price,ha! Seems unlikely we will see shares in the $2's again. $20 seems equally unlikely, just getting above that magic $5 in the next year or two would be a nice treat.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next